Jaktinib for Steroid-Refractory Acute Graft-Versus-Host Disease | MicrobiomeTrials← Back to trialsNCT07885228
Jaktinib for Steroid-Refractory Acute Graft-Versus-Host Disease
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-10-10Est. Completion: 2027-06-10
Enrollment target: 49 participants Locations- The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Hefei, Anhui, China
- Peking University People's Hosptial, Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
- Dongguan People's Hospital (The Tenth Affiliated Hospital of Southern Medical University), Dongguan, Guangdong, China
- General Hospital of Southern Theater Command, PLA, Guangzhou, Guangdong, China
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
- Guangzhou First People's Hospital (The Second Affiliated Hospital of South China University of Technology), Guangzhou, Guangdong, China
- Guangdong Second Provincial General Hospital (Guangdong Provincial Emergency Hospital), Guangzhou, Guangdong, China
- Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
- Huizhou Central People's Hospital, Huizhou, Guangdong, China
- Maoming People's Hospital, Maoming, Guangdong, China
- Shenzhen People's Hospital, Shenzhen, Guangdong, China
- The Seventh Affiliated Hospital (Shenzhen), Sun Yat-sen University, Shenzhen, Guangdong, China
Other microbiome trials you might be interested in
DOCK8 Deficiency
Background:
-DOCK8 deficiency is a genetic disorder that affects the immune system and can lead to severe recurrent inf…
Bethesda, United StatesEst. completion Oct 31, 2026
Graft Vs Host DiseaseAcute-graft-versus-host DiseaseChronic Graft-versus-host-disease
This study is about determining if an aerobic and resistance exercise intervention is feasible in patients diagnosed wit…
Boston, United StatesEst. completion Feb 28, 2027
Shenzhen Hospital of Southern Medical University, Shenzhen, Guangdong, ChinaHebei Yanda Lu Daopei Hospital, Langfang, Hebei, ChinaThe First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, ChinaUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaHunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, Hunan, ChinaXiangya Hospital of Central South University, Changsha, Hunan, ChinaThe First People's Hospital of Chenzhou, Chenzhou, Hunan, ChinaThe Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, ChinaThe First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaPhase 2
Recruiting
The investigators want to study if lower doses of chemotherapy will help babies with SCID to achieve good immunity with …
Birmingham, United StatesEst. completion Dec 1, 2027